Safety and Pharmacokinetics of MK-7680 in Participants With Hepatitis C (MK-7680-003)

NCT02269059 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

13

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C

Interventions

DRUG: MK-7680

Sponsor

Merck Sharp & Dohme LLC